Summit Trail Advisors’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Other funds holding DXCM
VCM
VPM
Summit Trail Advisors's DXCM Position: Q1 2026 in Review
Summit Trail Advisors increased its DexCom (DXCM) stake by 40% in Q1 2026, buying an estimated $534K and bringing the position to 26,697 shares worth $1.68M. The position accounts for 0.02% of the portfolio, ranked #657.
Summit Trail Advisors first reported a position in DXCM in Q4 2017 and has held it in 9 quarters since. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Summit Trail Advisors held 26,697 shares of DexCom worth $1.68M as of Q1 2026.
- Summit Trail Advisors bought 7,669 DexCom shares in Q1 2026, an estimated $534K.
- DexCom made up 0.02% of Summit Trail Advisors's portfolio in Q1 2026, its #657 holding.
- Summit Trail Advisors first reported a position in DexCom in Q4 2017 and has held it in 9 quarters since.
- 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Summit Trail Advisors's 13F filing for Q1 2026, filed 12 May 2026.